Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ia V, Polonskaia"'
Autor:
Iu I, Ragino, A M, Cherniavskiĭ, Ia V, Polonskaia, A M, Volkov, E V, Kashtanova, S Iu, Tsymbal, E M, Polovnikova
Publikováno v:
Kardiologiia. 52(5)
Concentrations of tumor necrosis factor, interleukin 1- and its receptor antagonist, IL-6, IL-8, IL-18, IL-2, ligand of CD40 receptor (CD40L), high sensitive C-reactive protein (hsCRP), monocyte chemotactic protein -1, endothelial monocyte activating
Autor:
Iu I, Ragino, A D, Kuimov, Ia V, Polonskaia, E V, Kashtanova, N G, Lozhkina, T A, Balabushevich, N V, Eremenko, U N, Negmadzhonov
Publikováno v:
Kardiologiia. 52(2)
Some inflammatory cytokines and parameters of low density lipoproteins (LDL) oxidative modification were studied in blood of 250 acute coronary syndrome (ACS) patients--Siberian inhabitants, men and women with myocardial infarction (MI) or unstable a
Autor:
Iu I, Ragino, A M, Cherniavskiĭ, N V, Eremenko, E V, Shakhtshneĭder, Ia V, Polonskaia, S Iu, Tsymbal, M V, Ivanova, M I, Voevoda
Publikováno v:
Kardiologiia. 51(3)
Laboratory lipid and lipoprotein biomarkers (total cholesterol - CH, triglycerides - TG, low-density and high-density lipoprotein cholesterol- LDL-CH, HDL-CH, apolipoproteins B and A1 - apoB, apoA1), carbohydrate biomarkers (plasma glucose, basal ins
Publikováno v:
Kardiologiia. 49(9)
The highest oxidative modification of fibrinogen was found in acute myocardial infarction (MI) men and it was 1.26 and 1.56 times higher in comparison with coronary heart disease (CHD) men with anamnesis of MI and with men without CHD, respectively.
Autor:
Iu I, Ragino, A M, Cherniavskiĭ, Ia V, Polonskaia, A M, Volkov, E V, Semaeva, S Iu, Tsymbal, M I, Voevoda
Publikováno v:
Kardiologiia. 49(6)
We studied men with coronary atherosclerosis without acute coronary syndrome and determined typical valuable parameters of inflammatory (tumor necrotic factor, antagonist of receptor to interleukin [IL] 1, IL 6, IL 8, monocytes chemotactic protein 1,
Publikováno v:
Kardiologiia. 47(9)
We studied parameters of inflammatory (tumor necrosis factor a, antagonist of interleukin-1 receptor, interleukin-6 , interleukin-8, C-reactive protein) and destructive (matrix metalloproteinases type 3 and 9, tissue inhibitor of metalloproteinase ty
Autor:
Iu I, Ragino, Ia V, Polonskaia, E V, Semaeva, E V, Kashtanova, I V, Kulikov, A M, Cherniavskiĭ, M I, Voevoda
Publikováno v:
Kardiologiia. 47(11)
We studied parameters of structural and oxidative modification of low density lipoproteins (LDL) in 80 men aged 35 - 65 years with coronary atherosclerosis verified at coronary angiography in comparison with 80 men of the same age without ischemic he
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (1)
The purpose of the present study was to develop a new procedure for determining the oxidative modification of plasma fibrinogen. The procedure was developed to use blood plasma from 96 males aged 35-60 years who had cardiovascular diseases: 49 patien
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 19
The aim of the study was to investigate the effects of cytoprotectional drug Mildronate ("Grindex", Latvia) on some parameters of oxidative processes and endothelial function in elderly patients with coronary heart disease (CHD). One hundred seventee